Skip to main content
. 2017 Aug 8;22(8):1298. doi: 10.3390/molecules22081298
ANOVA analysis of variance
AUC area under concentration-time curve
Cmax peak plasma concentration
CAA chloroacetaldehyde
CL clearance
CTX cyclophosphamide
DCCTX 2-dechloroethylcyclophosphamide
CYP450 cytochrome P450
DDIs drug-drug interactions
Gom A gomisin A
Gom C gomisin C
HLMs human liver microsomes
IC50 half maximal inhibitory concentration
IS internal standard
Keto ketoconazole
Ki dissociation constant for reversible inhibition
kobs initial inactivation rate constant
kinact the maximal inactivation rate constant
KI half maximal inhibitory concentration for MBI
LLOQ lower limit of quantification
LSD least significant difference
MBI mechanism-based inhibition
MI metabolite-intermediate
MRT mean residence time
NADPH dihydronicotinamide adenine dinucleotide phosphate
NADPH-gs NADPH regenerating system
PBS potassium phosphate buffer
SCE Schisandra chinensis extract
SD standard deviation
t1/2 terminal half-life
Tes testosterone
TDI time-dependent inhibition
Tmax time of plasma concentration reach a maximum
TNZ tinidazole
Vmax maximum reaction rate
Vd apparent volume of distribution
6OH-Tes 6β-hydroxytestosterone.